Barclays Raises Hims & Hers (HIMS) Target to $29 After Novo Deal Clears Legal Overhang

Barclays has increased its price target for Hims & Hers (HIMS) to $29 following the clearance of a legal overhang related to the Novo Nordisk deal, which has also led to a surge in Hims & Hers stock.